2001
Douching practices among HIV infected and uninfected adolescents in the United States
Vermund S, Sarr M, Murphy D, Levin L, Abdalian S, Ma Y, Crowley-Nowick P, Wilson C, network T. Douching practices among HIV infected and uninfected adolescents in the United States. Journal Of Adolescent Health 2001, 29: 80-86. PMID: 11530307, DOI: 10.1016/s1054-139x(01)00284-1.Peer-Reviewed Original ResearchConceptsYoung womenMultivariable logistic regression modelHIV uninfected subjectsBaseline interview dataMultiple logistic regressionHispanic/LatinaLogistic regression modelsRace/ethnicityRecent douchingUninfected subjectsHIV infectionHIV StudyUninfected adolescentsNationwide studyHIVSociodemographic factorsAdolescent womenLogistic regressionOne-way analysisActive femalesSexual behaviorWomenDouchingAdolescentsFemales
1998
Analysis of Intercurrent Human Immunodeficiency Virus Type 1 Infections in Phase I and II Trials of Candidate AIDS Vaccines
Graham B, McElrath M, Connor R, Schwartz D, Gorse G, Keefer M, Mulligan M, Matthews T, Wolinsky S, Montefiori D, Vermund S, Lambert J, Corey L, Belshe R, Dolin R, Wright P, Korber B, Wolff M, Fast P, Group A. Analysis of Intercurrent Human Immunodeficiency Virus Type 1 Infections in Phase I and II Trials of Candidate AIDS Vaccines. The Journal Of Infectious Diseases 1998, 177: 310-309. PMID: 9466516, DOI: 10.1086/514209.Peer-Reviewed Original ResearchMeSH KeywordsAdultAIDS VaccinesAmino Acid SequenceCD4 Lymphocyte CountFemaleHIV AntibodiesHIV Envelope Protein gp120HIV InfectionsHIV-1HumansImmunity, ActiveIncidenceMaleMiddle AgedMolecular Sequence DataNeutralization TestsPeptide FragmentsRisk-TakingSequence AnalysisSubstance Abuse, IntravenousViral LoadConceptsHIV-1 infectionHuman immunodeficiency virus type 1 (HIV-1) infectionVirus type 1 infectionCandidate AIDS vaccinesType 1 infectionAIDS vaccinePhase IHigh-risk sexual exposureVaccine-induced immune responsesComplete immunization scheduleEarly clinical courseCD4 lymphocyte countIntravenous drug useV3 loop amino acid sequencesUninfected subjectsVaccine recipientsLymphocyte countClinical courseImmunization scheduleSexual exposureVirus loadImmune responseControl groupDrug useInfection